Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 280,000 shares at $57.14 ($16.1M) on 2022-11-11, disclosed to the SEC on 2022-11-15.
Open-market sale of $16.1M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.14 | 36,800 | $2.1M | 13.0% |
| 2 | $58.70 | 58,667 | $3.4M | 21.3% |
| 3 | $58.70 | 58,667 | $3.4M | 21.3% |
| 4 | $56.80 | 62,933 | $3.6M | 22.1% |
| 5 | $56.80 | 62,933 | $3.6M | 22.1% |
| Total | $57.64 avg | 280,000 |
| $16.1M |
| 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-08-08 | $13.2M | — | Filing → |